A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137).

F T Valentine; S Kundu; P A Haslett; D Katzenstein; L Beckett; C Spino; M Borucki; M Vasquez; G Smith; J Korvick

doi:10.1093/infdis/173.6.1336

A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137).

NobleID: NI0P43W08R84S87
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/050D3FDB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/050D3FDB.svg?ark=w1%2F20260515%2F050D3FDB&value=id)](https://nobleid.org/work/w1/20260515/050D3FDB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137).

NobleID: NI0P43W08R84S87
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/050D3FDB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/050D3FDB.svg?ark=w1%2F20260515%2F050D3FDB&value=id)](https://nobleid.org/work/w1/20260515/050D3FDB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work